$ZYME: Zymeworks Submits Investigational New Drug (IND) Application for …

Date: Saturday, December 8th, 2018

Stock(s) mentioned:

Source: Business Wire (https://www.businesswire.com)

Summary: VANCOUVER, Canada–(BUSINESS WIRE)–Zymeworks Inc. (NYSE/TSX: ZYME), a clinical-stage biopharmaceutical company developing multifunctional …

Full article address: https://www.businesswire.com/news/home/20181208005005/en/Zymeworks-Submits-Investigational-New-Drug-IND-Application

Related News:

$ZYME: Zymeworks Reports 2018 Year-End Financial Results

$ZYME: Zymeworks to Present at Barclays 2019 Global Healthcare Conference

$ZYME: Zymeworks Reports Second Investigational New Drug (IND …

$ZYME: Zymeworks outlines 2019 priorities

$ZYME: Zymeworks Highlights 2018 Achievements and Announces 2019 …

$ZYME $FISI: Here is What Hedge Funds Think About Zymeworks Inc. (ZYME)

$PACQ $ZYME $MUI: Is Vishay Precision Group Inc (VPG) A Good Stock To Buy?

$PACQ $ZYME $MUI: Is Pure Acquisition Corp. (PACQ) A Good Stock To Buy?

$ZYME: Zymeworks Inc.: A Blockbuster In The Making

$ZYME: Zymeworks presents IND-enabling data of ZW49 at the San Antonio …

$BGNE $ZYME: Week In Review: BeiGene Forges $1.3 Billion Bi-Specific Antibody …

Latest News:

$MO: Why Marlboro Maker Bet on Juul, the Vaping Upstart Aiming to Kill Cigarettes

$MO: CEO Q&A: Altria Boss on Getting Into Weed, Taking Risks

$ABB: Duerr – A Good Play For Digitalization

$ARLO: ARLO 72 HOUR DEADLINE ALERT: Approximately 72 Hours …


$FB: FEMA Officials Accidentally Released Private Data From 2.3 Million Disaster Victims

$AMZN: Is Amazon’s Private-Label Business a Paper Tiger?

$BITA: Auto Sales in China Are Weak, but Bitauto Is Gaining Market Share

$BPI: The Law Offices of Timothy L. Miles Announces Investigation on …

$RUN $VSLR $SPWR: The US Solar Industry Shows Resilience in 2018

$WFC: Sens. Warren, Brown: Boot Wells Fargo CEO